Cargando…
Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials”
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189995/ https://www.ncbi.nlm.nih.gov/pubmed/37198651 http://dx.doi.org/10.1186/s13054-023-04484-9 |
| _version_ | 1785043198034313216 |
|---|---|
| author | Gutierrez, Manuel Alberto Guerrero Meade-Aguilar, José A. Martinez, Diego Escarraman |
| author_facet | Gutierrez, Manuel Alberto Guerrero Meade-Aguilar, José A. Martinez, Diego Escarraman |
| author_sort | Gutierrez, Manuel Alberto Guerrero |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10189995 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-101899952023-05-18 Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” Gutierrez, Manuel Alberto Guerrero Meade-Aguilar, José A. Martinez, Diego Escarraman Crit Care Correspondence BioMed Central 2023-05-17 /pmc/articles/PMC10189995/ /pubmed/37198651 http://dx.doi.org/10.1186/s13054-023-04484-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correspondence Gutierrez, Manuel Alberto Guerrero Meade-Aguilar, José A. Martinez, Diego Escarraman Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title | Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title_full | Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title_fullStr | Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title_full_unstemmed | Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title_short | Reply to “Propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| title_sort | reply to “propofol and survival: an updated meta‑analysis of randomized clinical trials” |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189995/ https://www.ncbi.nlm.nih.gov/pubmed/37198651 http://dx.doi.org/10.1186/s13054-023-04484-9 |
| work_keys_str_mv | AT gutierrezmanuelalbertoguerrero replytopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrials AT meadeaguilarjosea replytopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrials AT martinezdiegoescarraman replytopropofolandsurvivalanupdatedmetaanalysisofrandomizedclinicaltrials |